| human | Q5 |
| P496 | ORCID iD | 0000-0002-8896-4095 |
| P1153 | Scopus author ID | 36634621300 |
| P106 | occupation | researcher | Q1650915 |
| Q38099875 | Anti-inflammatory phytochemicals for chemoprevention of colon cancer. |
| Q35027361 | Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice |
| Q58795088 | Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives |
| Q39128652 | Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. |
| Q47186214 | Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. |
| Q36528118 | Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice |
| Q35027354 | Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling |
| Q34089260 | Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. |
| Q47407798 | Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. |
| Q104516453 | Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q36545140 | Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma |
| Q38793924 | Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer |
| Q36820882 | Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo |
| Q36021066 | Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression |
| Q34681112 | The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model. |
Search more.